Dr. Philip P. Storey, MD

Dr. Storey practices at Austin Retina Associates in Round Rock, Texas.

Dr. Storey's NPI, 1053614453, was assigned on December 7, 2010. Dr. Storey graduated from The Johns Hopkins University School of Medicine in 2012. Dr. Storey holds Texas license S2177.

Dr. Storey's primary practice is Austin Retina Associates, at 1545 Round Rock Ave, Round Rock, TX 78681 in Williamson County. The practice phone is (512) 451-0103.

Dr. Storey's primary practice is Austin Retina Associates in Round Rock, Texas. The medical group on file is CVS MinuteClinic. Dmand AI also links Dr. Storey to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Storey practices. Vendor and product names are available with a free account.

Ophthalmology is Dr. Storey's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Storey is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Storey's licenses on file in 3 states: Texas, California and Pennsylvania.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, dry eye, glaucoma, hereditary corneal conditions, hypertensive retinopathy and inflammation of iris among the conditions Dr. Storey treats.

CMS data shows 34,351 Medicare services from Dr. Storey across 27 procedure codes in 2024, for 1,075 Medicare patients. Medicare paid $4,044,486 for them.

CMS counts 1,075 Medicare patients who saw Dr. Storey in 2024. The largest group is 65 to 74, with 414 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 5% are also on Medicaid. Their average risk score is 1.46, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Storey's median patient age at 73, with 54% women.

In 2024, Dr. Storey wrote 451 Medicare Part D claims for 206 patients. 71% of them were for generic drugs. CMS names the drug for 412 of them, across 8 drugs with 11 or more claims each, at $8,771 in total drug cost. In 2023, CMS named 379 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Storey for performance year 2024, reported individually. Dr. Storey accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Cataract surgery: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 38 papers to Dr. Storey, published from 2008 to 2025. 2020 was the busiest year, with 5. The most frequent topics are Intravitreal Injections, Angiogenesis Inhibitors and Endophthalmitis. Dr. Storey has published most often in Retina. Dr. Storey's most frequent co-authors are Sunir Jain Garg, MD, Anthony Obeid, MD and James F. Vander, MD.

CMS Open Payments shows 216 general payments to Dr. Storey from 21 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 48% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $61,985. It also lists 2 research payments totaling $2,818 in 2024.

Dmand AI lists 6 awards for Dr. Storey, most recently Dr. Henry and Lilian Nesburn Award for Best Resident Research in 2015.

Dr. Storey graduated from The Johns Hopkins University School of Medicine in 2012. Dr. Storey is a member of AAO.

Dr. Storey is in network with 22 carriers, including Aetna, United Healthcare and Elevance. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.